Related Experiment Video
Updated: Jul 16, 2026

06:12
Detached Maize Sheaths for Live-Cell Imaging of Infection by Fungal Foliar Maize Pathogens
Published on: September 15, 2023
The Reversion of Sickled Cells by Cajanus cajan
1Department of Biochemistry, University of Port Harcourt, P.M.B. 5323 Port Harcourt, Nigeria.
Planta Medica
|December 1, 1985
Summary
Edible pigeon pea (Cajanus cajan) bean extracts demonstrated potential in sickle cell disease research. The in vitro study showed these extracts can prevent and reverse red blood cell sickling in patients with sickle cell anemia (HbSS).
Area of Science:
- Phytomedicine
- Hematology
- Cell Biology
Background:
- Sickle cell disease (SCD) is a genetic blood disorder characterized by abnormal hemoglobin (HbSS).
- Sickled erythrocytes lead to vaso-occlusion and organ damage.
- Current treatments for SCD are limited, necessitating research into novel therapeutic agents.
Purpose of the Study:
- To investigate the in vitro effects of Cajanus cajan bean extracts on sickle red blood cells.
- To determine the potential of Cajanus cajan as a natural remedy for sickle cell disease.
Main Methods:
- Preparation of boiled and crude ethanolic extracts from edible Cajanus cajan beans.
- In vitro testing using 14 blood samples from confirmed sickle cell (HbSS) patients.
- Assessment of erythrocyte morphology and sickling inhibition in sodium metabisulphite solution.
Main Results:
- Cajanus cajan extracts inhibited the sickling of erythrocytes in a chemical induction model.
- The extracts demonstrated the ability to revert already sickled erythrocytes to normal morphology.
- Significant improvement in the general morphology of sickle cell erythrocytes was observed upon exposure to the extracts.
Conclusions:
- Ethanolic extracts of Cajanus cajan beans possess antisickling properties.
- Cajanus cajan may offer a potential natural therapeutic approach for managing sickle cell disease.
- Further research into the active compounds and mechanisms of Cajanus cajan is warranted.
Related Concept Videos
Renewal of Intestinal Stem Cells
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...
Viral Recombination
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Lineage Commitment
Commitment is the process whereby stem cells:
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

